Your browser doesn't support javascript.
loading
Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.
Wu, Lian Qiu; Zhang, Wen Jian; Niu, Ji Xiao; Ye, Li Ya; Yang, Zhi Hua; Grau, Georges E; Lou, Jin Ning.
  • Wu LQ; Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, PR China.
J Vasc Res ; 45(1): 78-86, 2008.
Article en En | MEDLINE | ID: mdl-17901709
ABSTRACT
BACKGROUND/

AIMS:

The phenotypic and functional characteristics of microvascular endothelial cells derived from human liver cancer (HLCEC) were analyzed in vitro and compared with those of human liver sinusoidal endothelial cells (LSEC). METHODS AND

RESULTS:

Flow-cytometric and real-time PCR analysis indicated that expressions of tumor necrosis factor receptor (TNFR) p75, alphavbeta3 and alphavbeta5 were increased, while those of TNFR p55 and intercellular-adhesion molecule 1 (ICAM-1) were decreased in HLCEC compared with LSEC. The functional analysis indicated that HLCEC exhibited higher angiogenic ability than LSEC, including proliferation capacity, ability to form capillary-like networks and release of matrix metalloproteinases. In response to tumor necrosis factor, LSEC exhibited a significant dose-dependent cytotoxicity, while HLCEC did not. Moreover, the coagulant and fibrinolytic capacity was increased in HLCEC. In addition, tumor cell adherence was significantly higher on HLCEC than on LSEC, while leukocyte adherence was lower on HLCEC than on LSEC. The cytoadherence of HLCEC was inhibited by antibodies against alphavbeta3 and alphavbeta5,and of LSEC by antibodies against ICAM-1.

CONCLUSION:

These results indicate that tumor-derived endothelial cells are phenotypically and functionally different from those derived from normal liver tissue. These differences are valuable for understanding tumor angiogenesis and metastasis.
Asunto(s)
Células Endoteliales/patología; Neoplasias Hepáticas/irrigación sanguínea; Hígado/irrigación sanguínea; Neovascularización Patológica/patología; Adhesión Celular; Línea Celular; Movimiento Celular; Proliferación Celular; Forma de la Célula; Supervivencia Celular; Células Cultivadas; Relación Dosis-Respuesta a Droga; Células Endoteliales/efectos de los fármacos; Células Endoteliales/enzimología; Células Endoteliales/metabolismo; Citometría de Flujo; Humanos; Integrina alfaVbeta3/genética; Integrina alfaVbeta3/metabolismo; Integrinas/genética; Integrinas/metabolismo; Molécula 1 de Adhesión Intercelular/genética; Molécula 1 de Adhesión Intercelular/metabolismo; Hígado/metabolismo; Hígado/patología; Neoplasias Hepáticas/metabolismo; Neoplasias Hepáticas/patología; Metaloproteinasas de la Matriz/metabolismo; Microcirculación/patología; Neovascularización Patológica/enzimología; Neovascularización Patológica/metabolismo; Fenotipo; Inhibidor 1 de Activador Plasminogénico/metabolismo; ARN Mensajero/metabolismo; Receptores Tipo II del Factor de Necrosis Tumoral/genética; Receptores Tipo II del Factor de Necrosis Tumoral/metabolismo; Receptores de Vitronectina/genética; Receptores de Vitronectina/metabolismo; Reacción en Cadena de la Polimerasa de Transcriptasa Inversa; Tromboplastina/metabolismo; Factores de Tiempo; Activador de Tejido Plasminógeno/metabolismo; Factor de Necrosis Tumoral alfa/farmacología; Activador de Plasminógeno de Tipo Uroquinasa/metabolismo
Search on Google
Banco de datos: MEDLINE Asunto principal: Células Endoteliales / Hígado / Neoplasias Hepáticas / Neovascularización Patológica Idioma: En Año: 2008 Tipo del documento: Article
Search on Google
Banco de datos: MEDLINE Asunto principal: Células Endoteliales / Hígado / Neoplasias Hepáticas / Neovascularización Patológica Idioma: En Año: 2008 Tipo del documento: Article